Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00491426 · ClinicalTrials.gov registry record
Antimicrobial PK in Infants With Suspected or Confirmed Infection
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 450
- Enrollment target
NCT00491426 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 450 participants.
The verdict
NCT00491426 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
The purpose of this protocol is to provide a mechanism for the ongoing collection of blood and urine samples in newborns that will be used to measure levels of antimicrobial products used in the newborn population where there are limited pharmacokinetic data in either premature or term infants.
Interventions
- DRUG Metronidazole
- DRUG Acyclovir
- DRUG Ampicillin
- DRUG Amphotericin B
- DRUG Piperacillin/Tazobactam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00491426
The ClinicalTrials.gov registry entry for NCT00491426 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Metronidazole is the first listed.
NCT00491426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00491426 about?
NCT00491426 is a clinical study titled "Antimicrobial PK in Infants With Suspected or Confirmed Infection". The purpose of this protocol is to provide a mechanism for the ongoing collection of blood and urine samples in newborns that will be used to measure levels of antimicrobial products used in the newborn population where there are limited pharmacokinetic data in either premature or term infants.
What is the current status of trial NCT00491426?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2006-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00491426?
The interventions under investigation include: Metronidazole (DRUG), Acyclovir (DRUG), Ampicillin (DRUG), Amphotericin B (DRUG), Piperacillin/Tazobactam (DRUG).
Who is sponsoring clinical trial NCT00491426?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.